Roth JA - Search Results

1

Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancer.

Sepesi B, Zhou N, William WN Jr, Lin HY, Leung CH, Weissferdt A, Mitchell KG, Pataer A, Walsh GL, Rice DC, Roth JA, Mehran RJ, Hofstetter WL, Antonoff MB, Rajaram R, Negrao MV, Tsao AS, Gibbons DL, Lee JJ, Heymach JV, Vaporciyan AA, Swisher SG, Cascone T. Sepesi B, et al. Among authors: roth ja. J Thorac Cardiovasc Surg. 2022 Nov;164(5):1327-1337. doi: 10.1016/j.jtcvs.2022.01.019. Epub 2022 Jan 23. J Thorac Cardiovasc Surg. 2022. PMID: 35190177 Free PMC article. Clinical Trial.

2

Prognostic significance of computed tomography in resected N2 lung cancer.

Cybulsky IJ, Lanza LA, Ryan MB, Putnam JB Jr, McMurtrey MM, Roth JA. Cybulsky IJ, et al. Among authors: roth ja. Ann Thorac Surg. 1992 Sep;54(3):533-7. doi: 10.1016/0003-4975(92)90449-e. Ann Thorac Surg. 1992. PMID: 1324657

3

Combination immunotherapy for advanced lung cancer.

Yang SC, Grimm EA, Roth JA. Yang SC, et al. Among authors: roth ja. J Natl Cancer Inst Monogr. 1992;(13):197-201. J Natl Cancer Inst Monogr. 1992. PMID: 1327033 Clinical Trial.

4

Long-term survival after resection of pulmonary metastases from carcinoma of the breast.

Lanza LA, Natarajan G, Roth JA, Putnam JB Jr. Lanza LA, et al. Among authors: roth ja. Ann Thorac Surg. 1992 Aug;54(2):244-7; discussion 248. doi: 10.1016/0003-4975(92)91377-l. Ann Thorac Surg. 1992. PMID: 1637212

5

Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial.

Yang SC, Grimm EA, Parkinson DR, Carinhas J, Fry KD, Mendiguren-Rodriguez A, Licciardello J, Owen-Schaub LB, Hong WK, Roth JA. Yang SC, et al. Among authors: roth ja. Cancer Res. 1991 Jul 15;51(14):3669-76. Cancer Res. 1991. PMID: 1648441 Clinical Trial.

6

Resectability of small-cell lung cancer following induction chemotherapy in patients with limited disease (stage II-IIIb).

Zatopek NK, Holoye PY, Ellerbroek NA, Hong WK, Roth JA, Ryan MB, Komaki R, Pang AC, Glisson BS. Zatopek NK, et al. Among authors: roth ja. Am J Clin Oncol. 1991 Oct;14(5):427-32. doi: 10.1097/00000421-199110000-00013. Am J Clin Oncol. 1991. PMID: 1659177

7

Low-dose continuous infusion cisplatin combined with external beam irradiation for advanced colorectal adenocarcinoma and unresectable non-small cell lung carcinoma.

Ellerbroek NA, Fossella FV, Rich TA, Ajani JA, Komaki R, Roth JA, Holoye PY. Ellerbroek NA, et al. Among authors: roth ja. Int J Radiat Oncol Biol Phys. 1991 Feb;20(2):351-5. doi: 10.1016/0360-3016(91)90119-o. Int J Radiat Oncol Biol Phys. 1991. PMID: 1846848 Clinical Trial.

8

Improved survival after resection of pulmonary metastases from malignant melanoma.

Gorenstein LA, Putnam JB, Natarajan G, Balch CA, Roth JA. Gorenstein LA, et al. Among authors: roth ja. Ann Thorac Surg. 1991 Aug;52(2):204-10. doi: 10.1016/0003-4975(91)91337-u. Ann Thorac Surg. 1991. PMID: 1863140

9

Oncogene activation in esophageal cancer.

Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B, Roth JA. Casson AG, et al. Among authors: roth ja. J Thorac Cardiovasc Surg. 1991 Nov;102(5):707-9. J Thorac Cardiovasc Surg. 1991. PMID: 1943188

10

Response to chemotherapy does not predict survival after resection of sarcomatous pulmonary metastases.

Lanza LA, Putnam JB Jr, Benjamin RS, Roth JA. Lanza LA, et al. Among authors: roth ja. Ann Thorac Surg. 1991 Feb;51(2):219-24. doi: 10.1016/0003-4975(91)90789-s. Ann Thorac Surg. 1991. PMID: 1989534

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,236 results

Search Page